PPT Slide
General
- Bertz et al. Clin Pharmacokinet 1997;32:210-58.
- Hansten PD. Science Med 1998:16-25.
Interactions in HIV
- Piscitelli SC, Gallicano KD. N Engl J Med 2001;344:984-96.
- Tseng A, Foisy MM. Ann Pharmacother 1999;33(4):461-473
- Tseng A, Foisy M. Ann Pharmacother 1997;31:1040-58.
Internet:
- Toronto General Hospital Immunodeficiency Clinic, www.tthhivclinic.com
- Medscape HIV/AIDS Clinical Calculator, www.medscape.com/Medscape/ HIV/Druginteractions/index.cfm
- Liverpool HIVPharmacology Group, www.hiv-druginteractions.org
Notes:
Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997;32:210-58.
Hansten PD. Understanding drug-drug interactions. Science Med 1998:16-25.
Tseng A, Foisy MM. Update on
Tseng A, Foisy M. Management of drug interactions in patients with HIV. Ann Pharmacother 1997;31:1040-58.
Toronto General Hospital Immunodeficiency Clinic, www.tthhivclinic.com
Medscape HIV/AIDS Clinical Calculator, www.medscape.com/Medscape/ HIV/Druginteractions/index.cfm
Liverpool HIVPharmacology Group, www.hiv-druginteractions.org